Paper1865542
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
Greenman RL and 9 others. JAMA, 1991. Cited by 580 papers, by iCite.
Cite this record
ConductScience Library. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. Papers, record 1865542. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1865542
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Endotoxins | Major topic |
| Gram-Negative Bacteria | Major topic |
| Immunoglobulin M | Major topic |
| Sepsis | Major topic |
| Aged | |
| Clinical Protocols | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Multiple Organ Failure | |
| Prospective Studies | |
| Shock, Septic |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 1865548 | Monoclonal antibodies to endotoxin. New allies against sepsis? | https://conductscience.org/library/papers/1865548 |
Source PubMed
Cited by121
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 580 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41751298 | Modes of (Inter)Actions of Polyvalent Immunoglobulins: Nonclinical and Clinical Research in Severe Bacterial Infections. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751298 | PubMed |
| 41009426 | Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009426 | PubMed |
| 40904815 | Circulating TNF-α levels in rheumatoid arthritis: a systematic review and meta-analysis and comparison to TNF-α levels in sepsis. | Ther Adv Infect Dis | 2025 | https://conductscience.org/library/papers/40904815 | PubMed |
| 38860003 | The effect of polyclonal and monoclonal based antibodies as promising potential therapy for treatment of sepsis: A systematic review. | New Microbes New Infect | 2024 | https://conductscience.org/library/papers/38860003 | PubMed |
| 38017475 | Positive single-center randomized trials and subsequent multicenter randomized trials in critically ill patients: a systematic review. | Crit Care | 2023 | https://conductscience.org/library/papers/38017475 | PubMed |
| 37432116 | Hit 'em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target. | Microbiol Mol Biol Rev | 2023 | https://conductscience.org/library/papers/37432116 | PubMed |
| 35814227 | Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35814227 | PubMed |
| 33066119 | Structure, Function, and Therapeutic Use of IgM Antibodies. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/33066119 | PubMed |
| 32936727 | Targeted IgMs agonize ocular targets with extended vitreal exposure. | MAbs | 2020 | https://conductscience.org/library/papers/32936727 | PubMed |
| 32849612 | Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849612 | PubMed |
| 32288619 | Let the Cells Speak: Neutrophils as Biologic Markers of the Inflammatory Response. | Sepsis (Boston) | 1998 | https://conductscience.org/library/papers/32288619 | PubMed |
| 29549641 | Engineering Antibodies for the Treatment of Infectious Diseases. | Adv Exp Med Biol | 2017 | https://conductscience.org/library/papers/29549641 | PubMed |
| 29222409 | Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae. | Nat Commun | 2017 | https://conductscience.org/library/papers/29222409 | PubMed |
| 28469079 | Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4. | JCI Insight | 2017 | https://conductscience.org/library/papers/28469079 | PubMed |
| 28115287 | Microbial recognition and danger signals in sepsis and trauma. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/28115287 | PubMed |
| 26771793 | Endotoxin: Back to the Future. | Crit Care Med | 2016 | https://conductscience.org/library/papers/26771793 | PubMed |
| 25538412 | Alteco endotoxin hemoadsorption in Gram-negative septic shock patients. | Indian J Crit Care Med | 2014 | https://conductscience.org/library/papers/25538412 | PubMed |
| 25190187 | Strategies to improve drug development for sepsis. | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/25190187 | PubMed |
| 24916483 | The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. | Trials | 2014 | https://conductscience.org/library/papers/24916483 | PubMed |
| 24351718 | Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect. | Toxins (Basel) | 2013 | https://conductscience.org/library/papers/24351718 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1865542
GET https://conductscience.org/api/papers/v1/1865542/cited_by?page=2